                         SEQUENCE LISTING

<110>  Fukuda, Michiko
 
<120>  METHODS AND COMPOSITIONS RELATED TO ANNEXIN-1 BINDING COMPOUNDS

<130>  24520.47.9001

<160>  24    

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(7)

<400>  1

Ile Glu Leu Leu Gln Ala Arg 
1               5           


<210>  2
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(7)

<400>  2

Ile Phe Leu Leu Trp Gln Arg 
1               5           


<210>  3
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(7)

<400>  3

Ile Ile Leu Leu Gln Ala Arg 
1               5           


<210>  4
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(7)

<400>  4

Ile Asp Leu Met Gln Ala Arg 
1               5           


<210>  5
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(7)

<400>  5

Ile Ser Leu Leu Gln Ala Arg 
1               5           


<210>  6
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(7)

<400>  6

Phe Ser Leu Leu Asp Ala Arg 
1               5           


<210>  7
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(7)

<400>  7

Ile Ser Leu Leu Gly Ala Arg 
1               5           


<210>  8
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(7)

<400>  8

Pro Leu Trp Arg Pro Ser Arg 
1               5           


<210>  9
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(7)

<400>  9

Leu Leu Leu Met Gln Leu Arg 
1               5           


<210>  10
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(7)

<400>  10

Leu Tyr Leu Gln Arg Leu Arg 
1               5           


<210>  11
<211>  346
<212>  PRT
<213>  Rattus norvegicus


<220>
<221>  PEPTIDE
<222>  (1)..(346)
<223>  Anxa1 fragment

<400>  11

Met Ala Met Val Ser Glu Phe Leu Lys Gln Ala Arg Phe Leu Glu Asn 
1               5                   10                  15      


Gln Glu Gln Glu Tyr Val Gln Ala Val Lys Ser Tyr Lys Gly Gly Pro 
            20                  25                  30          


Gly Ser Ala Val Ser Pro Tyr Pro Ser Phe Asn Val Ser Ser Asp Val 
        35                  40                  45              


Ala Ala Leu His Lys Ala Ile Met Val Lys Gly Val Asp Glu Ala Thr 
    50                  55                  60                  


Ile Ile Asp Ile Leu Thr Lys Arg Thr Asn Ala Gln Arg Gln Gln Ile 
65                  70                  75                  80  


Lys Ala Ala Tyr Leu Gln Glu Asn Gly Lys Pro Leu Asp Glu Val Leu 
                85                  90                  95      


Arg Lys Ala Leu Thr Gly His Leu Glu Glu Val Val Leu Ala Met Leu 
            100                 105                 110         


Lys Thr Pro Ala Gln Phe Asp Ala Asp Glu Leu Arg Gly Ala Met Lys 
        115                 120                 125             


Gly Leu Gly Thr Asp Glu Asp Thr Leu Ile Glu Ile Leu Thr Thr Arg 
    130                 135                 140                 


Ser Asn Glu Gln Ile Arg Glu Ile Asn Arg Val Tyr Arg Glu Glu Leu 
145                 150                 155                 160 


Lys Arg Asp Leu Ala Lys Asp Ile Thr Ser Asp Thr Ser Gly Asp Phe 
                165                 170                 175     


Arg Lys Ala Leu Leu Ala Leu Ala Lys Gly Asp Arg Cys Gln Asp Leu 
            180                 185                 190         


Ser Val Asn Gln Asp Leu Ala Asp Thr Asp Ala Arg Ala Leu Tyr Glu 
        195                 200                 205             


Ala Gly Glu Arg Arg Lys Gly Thr Asp Val Asn Val Phe Thr Thr Ile 
    210                 215                 220                 


Leu Thr Ser Arg Ser Phe Pro His Leu Arg Arg Val Phe Gln Asn Tyr 
225                 230                 235                 240 


Gly Lys Tyr Ser Gln His Asp Met Asn Lys Ala Leu Asp Leu Glu Leu 
                245                 250                 255     


Lys Gly Asp Ile Glu Lys Cys Leu Thr Thr Ile Val Lys Cys Ala Thr 
            260                 265                 270         


Ser Thr Pro Ala Phe Phe Ala Glu Lys Leu Tyr Glu Ala Met Lys Gly 
        275                 280                 285             


Ala Gly Thr Arg His Lys Ala Leu Ile Arg Ile Met Val Ser Arg Ser 
    290                 295                 300                 


Glu Ile Asp Met Asn Glu Ile Lys Val Phe Tyr Gln Lys Lys Tyr Gly 
305                 310                 315                 320 


Ile Ser Leu Cys Gln Ala Ile Leu Asp Glu Thr Lys Gly Asp Tyr Glu 
                325                 330                 335     


Lys Ile Leu Val Ala Leu Cys Gly Gly Asn 
            340                 345     


<210>  12
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(11)

<400>  12

Ile Phe Leu Leu Trp Gln Arg Lys Lys Lys Cys 
1               5                   10      


<210>  13
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; selectin ligand mimic


<220>
<221>  PEPTIDE
<222>  (1)..(7)

<400>  13

Ile Glu Leu Leu Gln Ala Arg 
1               5           


<210>  14
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(8)

<400>  14

Ile Phe Leu Leu Trp Gln Arg Cys 
1               5               


<210>  15
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; control peptide


<220>
<221>  peptide
<222>  (1)..(7)

<400>  15

Arg Gln Trp Leu Leu Phe Ile 
1               5           


<210>  16
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized;  control peptide


<220>
<221>  peptide
<222>  (1)..(10)

<400>  16

Arg Gln Trp Leu Leu Phe Ile Cys Arg Arg 
1               5                   10  


<210>  17
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(9)

<400>  17

Ile Phe Leu Leu Trp Gln Arg Cys Arg 
1               5                   


<210>  18
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  PEPTIDE
<222>  (1)..(11)

<400>  18

Ile Phe Leu Leu Trp Gln Arg Cys Arg Arg Arg 
1               5                   10      


<210>  19
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(10)

<400>  19

Ile Phe Leu Leu Trp Gln Arg Cys Arg Arg 
1               5                   10  


<210>  20
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(11)

<400>  20

Ile Phe Leu Leu Trp Gln Arg Xaa Xaa Xaa Xaa 
1               5                   10      


<210>  21
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding compound


<220>
<221>  peptide
<222>  (1)..(12)

<400>  21

Ile Phe Leu Leu Trp Gln Arg Cys Xaa Xaa Xaa Xaa 
1               5                   10          


<210>  22
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; annexin-1 binding peptide


<220>
<221>  peptide
<222>  (1)..(12)

<400>  22

Ile Phe Leu Leu Trp Gln Arg Cys Arg Arg Arg Arg 
1               5                   10          


<210>  23
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; cleavage site for enterokinase


<220>
<221>  peptide
<222>  (1)..(5)

<400>  23

Asp Asp Asp Asp Lys 
1               5   


<210>  24
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chemically synthesized; therapeutic agent


<220>
<221>  peptide
<222>  (1)..(14)

<400>  24

Lys Leu Ala Lys Leu Ala Lys Lys Leu Ala Lys Leu Ala Lys 
1               5                   10                  


